Yalei Zhang
No. 151, Yanjiang Rd
Guangzhou, 510120, China
Guangzhou, 510120, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Primary thymic mucoepidermoid carcinoma with positive MAML2 gene rearrangement: a case report.
Journal: Gland surgery
Published: December 18, 2025
Pathological complete response in RET-positive non-small cell lung cancer: a case report of pralsetinib-based "sandwich" therapy.
Journal: Translational lung cancer research
Published: August 22, 2025
Pathological complete response and long-term survival by pembrolizumab based immunochemotherapy in epidermal growth factor receptor mutated non-small cell lung cancer post-tyrosine kinase inhibitor failure: a case report and tumor microenvironment analysis.
Journal: Translational lung cancer research
Published: August 13, 2024
Dissecting the genetic variations associated with response to first-line chemotherapy in patients with small cell lung cancer: a retrospective cohort study.
Journal: Journal of thoracic disease
Published: November 20, 2023
An original aneuploidy-related gene model for predicting lung adenocarcinoma survival and guiding therapy.
Journal: Scientific reports
Published: November 02, 2023
Efficacy of Intrapleural or Intrapericardial Injection of Single Bevacizumab in the Treatment of Lung Cancer-Mediated Malignant Effusion.
Journal: Canadian respiratory journal
Published: February 21, 2022
Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trial.
Journal: Signal transduction and targeted therapy
Published: May 05, 2021
Response to the combination use of pazopanib with olaratumab in a patient with lung-metastatic embryonal rhabdomyosarcoma: a case report.
Journal: Translational lung cancer research
Published: February 11, 2021
Neoadjuvant Four-Drug Combination Therapy for NSCLC With EGFR Mutation Avoiding Total Pneumonectomy.
Neoadjuvant Four-Drug Combination Therapy for NSCLC With EGFR Mutation Avoiding Total Pneumonectomy.
Journal: Frontiers in oncology
Published: March 28, 2020
The Impact of Anlotinib on Brain Metastases of Non-Small Cell Lung Cancer: Post Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303).
Journal: The oncologist
Published: November 04, 2019
Integrin β4-Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis.
Journal: Cancer research
Published: April 09, 2019
How to optimize the treatment strategy for patients with EGFR-mutant stage IA lung adenocarcinoma: an international multidisciplinary team.
Journal: Journal of thoracic disease
Published: August 03, 2018
Last Updated: 09/26/2026